EDGAR Filing Documents for 0001144204-19-037896

Form F-1 - Registration statement for certain foreign private issuers:

SEC Accession No. 0001144204-19-037896

Filing Date

2019-08-06

Accepted

2019-08-06 16:40:27

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM F-1	tv526597_f1.htm	F-1	593581
2	EXHIBIT 4.6	tv526597_ex4-6.htm	EX-4.6	97029
3	EXHIBIT 5.1	tv526597_ex5-1.htm	EX-5.1	36922
4	EXHIBIT 23.1	tv526597_ex23-1.htm	EX-23.1	3531
5	GRAPHIC	logo-1.gif	GRAPHIC	3961
6	GRAPHIC	logo.gif	GRAPHIC	1932
	Complete submission text file	0001144204-19-037896.txt		740318

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1 | Act: 33 | File No.: 333-233048 | Film No.: 191002650
SIC: 2834 Pharmaceutical Preparations